Is Selling Colgate-Palmolive Company Here a Winning Strategy? Option Traders Hate The Stock


 Is Selling Colgate Palmolive Company Here a Winning Strategy? Option Traders Hate The Stock

In today’s session Colgate-Palmolive Company (CL) recorded an unusually high (1,152) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the October, 2016 put, expecting serious CL decrease. With 1,152 contracts traded and 124 open interest for the Oct, 16 contract, it seems this is a quite bearish bet. The option with symbol: CL161021P00070500 closed last at: $0.28 or 30% down. The stock decreased 1.11% or $0.82 during the last trading session, hitting $72.8. About 3.27 million shares traded hands or 10.10% up from the average. Colgate-Palmolive Company (NYSE:CL) has risen 9.34% since March 1, 2016 and is uptrending. It has outperformed by 0.10% the S&P500.

Analysts await Colgate-Palmolive Company (NYSE:CL) to report earnings on November, 4. They expect $0.73 earnings per share, up 1.39% or $0.01 from last year’s $0.72 per share. CL’s profit will be $646.27 million for 24.93 P/E if the $0.73 EPS becomes a reality. After $0.70 actual earnings per share reported by Colgate-Palmolive Company for the previous quarter, Wall Street now forecasts 4.29% EPS growth.

Colgate-Palmolive Company (NYSE:CL) Ratings Coverage

Out of 16 analysts covering Colgate-Palmolive (NYSE:CL), 3 rate it a “Buy”, 0 “Sell”, while 13 “Hold”. This means 19% are positive. $88 is the highest target while $65 is the lowest. The $72.54 average target is -0.36% below today’s ($72.8) stock price. Colgate-Palmolive has been the topic of 27 analyst reports since July 21, 2015 according to StockzIntelligence Inc. On Friday, January 15 the stock rating was upgraded by BNP Paribas to “Outperform”. Goldman Sachs upgraded Colgate-Palmolive Company (NYSE:CL) on Monday, May 2 to “Neutral” rating. The rating was downgraded by Sterne Agee CRT on Friday, February 26 to “Neutral”. The rating was initiated by Atlantic Securities with “Overweight” on Wednesday, January 6. UBS maintained the shares of CL in a report on Friday, July 29 with “Neutral” rating. On Wednesday, August 5 the stock rating was downgraded by Zacks to “Hold”. The firm has “Hold” rating by S&P Research given on Monday, November 2. The rating was initiated by Sterne Agee CRT on Tuesday, July 21 with “Buy”. The firm has “Neutral” rating by UBS given on Friday, April 29. The stock has “Sector Perform” rating given by RBC Capital Markets on Monday, January 4.

Insitutional Activity: The institutional sentiment decreased to 0.87 in 2016 Q2. Its down 0.04, from 0.91 in 2016Q1. The ratio fall, as 47 funds sold all Colgate-Palmolive Company shares owned while 440 reduced positions. 53 funds bought stakes while 371 increased positions. They now own 618.55 million shares or 5.94% less from 657.64 million shares in 2016Q1.
High Point National Bank & Trust holds 23,756 shares or 0.47% of its portfolio. Harvest Cap Management holds 0.21% or 6,183 shares in its portfolio. Pinnacle has 7,161 shares for 0.12% of their US portfolio. Chilton Investment Com Lc last reported 253,853 shares in the company. Security Bank & Trust Of Sioux City Iowa Ia has 1.55% invested in the company for 18,712 shares. Moreover, Meag Munich Ergo Kapitalanlagegesellschaft Mbh has 2.27% invested in Colgate-Palmolive Company (NYSE:CL) for 342,850 shares. Seaward Partnership last reported 199,307 shares in the company. Capital Invsts owns 994,200 shares or 0.11% of their US portfolio. The Texas-based Hourglass Ltd Liability Corporation has invested 0.39% in Colgate-Palmolive Company (NYSE:CL). Winch Advisory Svcs Ltd Liability Corporation owns 655 shares or 0.06% of their US portfolio. Ironsides Asset Advsrs Limited Liability Company owns 6,000 shares or 0.13% of their US portfolio. Washington Tru Bancorp has 0.07% invested in the company for 3,593 shares. Commonwealth Commercial Bank Of has 1.42% invested in the company for 1.66M shares. Ronald Blue & Com Ltd Limited Liability Company holds 8,221 shares or 0.03% of its portfolio. Cullinan Associate Incorporated reported 209,090 shares or 1.24% of all its holdings.

Insider Transactions: Since April 15, 2016, the stock had 0 insider purchases, and 18 selling transactions for $22.24 million net activity. Verduin Patricia had sold 3,666 shares worth $262,449 on Monday, May 16. On Tuesday, August 2 HANCOCK ELLEN M sold $342,954 worth of the stock or 4,584 shares. SADOVE STEPHEN I sold 8,803 shares worth $653,927. On Wednesday, May 11 HUSTON JOHN J sold $1.01M worth of the stock or 14,000 shares. $5.89 million worth of shares were sold by Wallace Noel R. on Tuesday, August 2. 89,200 Colgate-Palmolive Company (NYSE:CL) shares with value of $6.44 million were sold by Skala Justin. On Tuesday, May 3 Dolan Victoria L sold $1.39 million worth of the stock or 19,334 shares.

Colgate-Palmolive Company is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The company has a market cap of $64.45 billion. The Company’s divisions include Oral, Personal and Home Care, and Pet Nutrition. It has a 47.04 P/E ratio. The Oral, Personal and Home Care product segment is operated through over five geographic divisions, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply